WINNIPEG, Manitoba, Nov. 14, 2017 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) is pleased to announce its Q3 2017 Financial Results.
WINNIPEG, Manitoba, Nov. 14, 2017 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) is pleased to announce its Q3 2017 Financial Results.